February is here and the first big promotion is in launch mode:
Biotech Products Services & Research Inc. (BPSR)
Having been a ticker on radar for several months due to the set up, BPSR looks to be readying for the public by the group formerly known as Mike Statler’s StockTips.
The S1 was filed in September, 2014 by a favorite for pump and dumps, Cane Clark Agency, LLC, as Bespoke Tricycles, Inc.: A UK based start up focused on the development, manufacturing and commercialization of foldable/collapsible vending tricycle. It was confirmed that BPRS would be a promotion when they implemented the 18 for 1 split September 21, 2015.
Cane Clark Agency first appeared on my radar when the group fka Awesome Penny Stocks did a one-day smash & grab with VLNX back in August, 2012. The VLNX banner went up on the website and emails even came out from a hacked account, a hushmail account, only to have an “official” email be issued at the very end of the trading session saying “VLNX is not our next pick.” Didn’t really matter because over $100 million traded during the two sessions and the group was, at the time, splitting into two separate entities to ensure any SEC action would allow one of the entities to keep pumping stocks.
In any case, Cane Clark Agency, LLC, aka Cane Clark, LLP, became a set up station for numerous promotions since. What we have confirmed now with the websites and videos that are up and live is that BPSR is not only a promo due to be launched, but it’s Mikey’s old StockTips new name: WallStGiants, that’s going to be making their presence made.
StockTips launched themselves into the OTC promotion circle back in November, 2013 with their first pick, PGLO and ended their existence in June, 2015 with COLV. Here’s how their picks played out:
PGFY (Halted by SEC days after launch)
ECRY (Now BVTK after a 1:10 RS)
What To Expect
So, with BPSR, we have a new face (WallStGiants), but with the same pitch: a talk you through video as to why this is the greatest penny stock on the planet. It was actually quite odd that the shell was able to land CEO Albert Mitrani since his Analytical Stem Cell Corp. was raising funds, $3,500,000, back in 2014. Then again, Mitrani fits the profile perfectly when you consider the back room tourism surgeries South Florida became famous for and how he is even linked to pitching some impoverished Latin Americans how their autistic children would be able to speak normally after his stem cell treatment.
Back in June, 2015, Mitrani consummated the purchase of 7,500,000 shares of BPSR common stock from John Goodhew (87.8% of the issued and outstanding shares of the Company on a fully diluted basis). After the 18-1 forward stock split, effective September 21, 2015, 92,284,810 shares is what was reported, with 94,374,810 shares being the issued and outstanding as of October 29, 2015.
IF the 13D/A filed for Mitrani prior to the FS stated 4,160,000 owned, then Mitrani holds 74,880,000, making the float around 20 million or so. We can see that, during the fiscal year October 31, 2013, 840,000 shares of BPSR were issued for $42,000 (Page F-11).
After the FS, the 15,120,000 shares have a per share cost of $0.00277.
The pages are up, the video is both audible and legible, and the very first thing you see on the WallStGiants video is the TGRO tout before you hit play so, put 1+1+1 together and you get BPSR Stock Promotion. On Thursday and Friday, $4,974 and $7,908 was all the volume that hit the ticker. If the word has not gotten around as much as it appears, launch day is coming this week.
Bringing down the share price to launch or launching it from here is the question. PGLO & TGRO ran nice right out the gate and ran for two weeks before peaking. The others, well, once you throw your hat into the bull ring, you can expect its going to get stepped on. Won’t be too long before BPSR is printing $1.